After reporting phase 2b results for FLU-v, SEEK Group CEO Gregory Stoloff said the program is ready for phase 3. More: Universal flu vaccine biotech seeks Big Pharma partnership for phase 3 testing: CEO Source: fierce
read moreSanofi’s CFO search lasted two months and led the company to a financial executive from French automaker PSA Group: Jean-Baptiste Chasseloup de Chatillon. More: Sanofi recruits veteran French auto executive to replace outgoing CFO Contamine Source: fierce
read moreAllergan is in the middle of making some moves to revive its struggling shares. And what’s next may depend on how some closely watched pipeline products perform in the months to come, analysts say. More: What's next for embattled Allergan?
read moreThe FDA gave Indian generic drugmaker Glenmark its first supplemental Abbreviated New Drug Application approval for its manufacturing facility in Monroe, North Carolina, the company said. More: FDA gives Indian drugmaker Glenmark its first approval for generics produced at U.S.
read moreAtara Biotherapeutics has initiated construction of a new CAR-T gene therapy manufacturing facility in Thousand Oaks, California, where it will produce cells for allogeneic treatments. More: Atara Biotherapeutics building M CAR-T gene therapy plant in Southern California Source: fierce
read moreJanssen has presented data from pivotal Phase III clinical studies backing use of esketamine spray in treatment-resistant depression. More: Phase III success for Janssen’s esketamine in treatment-resistant depression Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals